<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".14" citation="COMAR 10.34.19.14" title_num="10" subtitle_num="34" chapter_num="19" heading="Training of Staff, Patient, and Caregiver.">
  <paragraph num="A.">
    <text>The pharmacist shall make counseling available to the patient or primary caregiver, or both, concerning proper use of compounded sterile preparations and related supplies furnished by the pharmacy.</text>
  </paragraph>
  <paragraph num="B.">
    <text>The permit holder shall ensure that pharmacy personnel engaging in compounding sterile preparations are trained and demonstrate competence in the safe handling and compounding of compounded sterile preparations and parenteral solutions, including cytotoxic agents if applicable.</text>
  </paragraph>
  <paragraph num="C.">
    <text>The permit holder shall maintain records of training and demonstrated competence for individual employees for 5 years.</text>
  </paragraph>
  <paragraph num="D.">
    <text>The permit holder shall ensure the continuing competence of pharmacy personnel engaged in compounding sterile preparations.</text>
  </paragraph>
  <paragraph num="E.">
    <text>A pharmacy that compounds sterile preparations shall comply with the following training requirements:</text>
    <paragraph num="(1)">
      <text>The pharmacy shall establish and follow a written program of training and performance evaluation designed to ensure that individuals working in the designated area have the knowledge and skills necessary to perform the assigned tasks properly and include at least the following:</text>
      <paragraph num="(a)">
        <text>Aseptic technique with media fill verification at a frequency defined by risk level as described in USP 797 Standards:</text>
        <paragraph num="(i)">
          <text>12 months for low and medium risk; and</text>
        </paragraph>
        <paragraph num="(ii)">
          <text>6 months for high risk;</text>
        </paragraph>
      </paragraph>
      <paragraph num="(b)">
        <text>Pharmaceutical calculations and terminology;</text>
      </paragraph>
      <paragraph num="(c)">
        <text>Compounding sterile preparation documentation process;</text>
      </paragraph>
      <paragraph num="(d)">
        <text>Quality assurance procedures;</text>
      </paragraph>
      <paragraph num="(e)">
        <text>Aseptic preparation procedures;</text>
      </paragraph>
      <paragraph num="(f)">
        <text>Proper cleansing, gowning, and gloving techniques;</text>
      </paragraph>
      <paragraph num="(g)">
        <text>General conduct in the controlled area;</text>
      </paragraph>
      <paragraph num="(h)">
        <text>Cleaning, sanitizing, and maintaining equipment used in the controlled area;</text>
      </paragraph>
      <paragraph num="(i)">
        <text>Sterilization techniques for high risk preparations; and</text>
      </paragraph>
      <paragraph num="(j)">
        <text>Container, equipment, and closure system selection.</text>
      </paragraph>
    </paragraph>
    <paragraph num="(2)">
      <text>Individuals assigned to the controlled area shall successfully complete practical skills training in aseptic technique and aseptic area practices.</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Evaluations shall include:</text>
      <paragraph num="(a)">
        <text>Written testing;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Observation for adherence to aseptic technique and aseptic area policies and procedures; and</text>
      </paragraph>
      <paragraph num="(c)">
        <text>Media fill verification as set forth in §E(1)(a) of this regulation.</text>
      </paragraph>
    </paragraph>
  </paragraph>
</regulation>